US Pharma MarketingThe post Intuitive’s shares fall 8% after tempering 2026 procedural growth outlook appeared first on Medical Device Network.
Intuitive’s shares fall 8% after tempering 2026 procedural growth outlook
The robotic surgery giant now expects procedural growth to fall at the 14% to 15% midpoint for 2026, versus between 13.5% and 15.5% previously. The robotic surgery giant now expects procedural growth to fall at the 14% to 15% midpoint for 2026, versus between 13.5% and 15.5% previously. Intuitive’s stock drop follows its tempered procedural growth outlook for 2026. Credit: viewimage/Shutterstock.com Intuitive reported strong Q3 growth, yet its shares fell by almost 8% after revealing a tempered robotic surgery procedural growth outlook for 2026. Quarterly revenues reached just over $3bn for Intuitive, indicative of a 22% year-over-year (YoY) uplift. However,…
The robotic surgery giant now expects procedural growth to fall at the 14% to 15% midpoint for 2026, versus between 13.5% and 15.5% previously.
Source: Medical Device Network